Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal...
Moderna
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal...
With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years...
Personalis (NASDAQ: PSNL) announced two significant agreements: a $50 million investment from Merck through private...
